Subscribe
shutterstock_2142775731_artemisdiana
ArtemisDiana / Shutterstock.com
12 June 2023FeaturesBiotechnologyLauris Kemp, Claire Irvine and Susan Keston

Bioinformatics: a guide to IP protection

Bioinformatics is a buzzword at the moment. The ability of modern computing systems to process complex biological data has meant healthcare and biotech is changing.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
COVID-19: Protection of IP for AI tools
1 September 2020   As AI becomes a crucial weapon in the battle against the global pandemic, companies in the field need to ensure that their valuable IP is protected, as Mao Xiao Hong and Danny Yap of IPOS International explain.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Asia
COVID-19: Protection of IP for AI tools
1 September 2020   As AI becomes a crucial weapon in the battle against the global pandemic, companies in the field need to ensure that their valuable IP is protected, as Mao Xiao Hong and Danny Yap of IPOS International explain.

More on this story

Asia
COVID-19: Protection of IP for AI tools
1 September 2020   As AI becomes a crucial weapon in the battle against the global pandemic, companies in the field need to ensure that their valuable IP is protected, as Mao Xiao Hong and Danny Yap of IPOS International explain.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Panitch Schwarze brings in molecular biologist
ITC concludes row over biotech lab equipment between US and German rivals
USPTO clarifies AI's role in patent eligibility
Sanofi and Regeneron triumph in UPC decision against Amgen
FTC supports USPTO terminal disclaimer plan amid opposition
Labour govt appoints new Minister with IP oversight